Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants

Muhammad Tahir ul Qamar; Safar M. Alqahtani; Mubarak A. Alamri; Ling‐Ling Chen

doi:10.1016/j.jpha.2020.03.009

Keywords

CoronavirusDrug discoveryVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Middle East respiratory syndrome coronavirusCysteine proteaseCoronavirus disease 2019 (COVID-19)Viral replicationDrugDrug developmentProteaseCoronaviridaeAntiviral drugPandemicChemistrySevere acute respiratory syndrome coronavirusViral life cycleComputational biologyBiologyEnzymeVirusPharmacologyInfectious disease (medical specialty)DiseaseBiochemistryMedicine

Affiliated Institutions

Related Publications

An oral SARS-CoV-2 M <sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen , Charlotte Allerton , Annaliesa S. Anderson +40 more

Path to another drug against COVID-19 The rapid development of vaccines has been crucial in battling the ongoing COVID-19 pandemic. However, access challenges remain, breakthrou...

2021 Science 1754 citations

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai , Kiyoko Iwatsuki‐Horimoto , Masato Hatta +31 more

Significance Since SARS-CoV-2 emerged in China, it has spread rapidly around the world. Effective vaccines and therapeutics for SARS-CoV-2−induced disease (coronavirus disease 2...

2020 Proceedings of the National Academy o... 1134 citations

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

Wenhao Dai , Bing Zhang , Xia-Ming Jiang +24 more

Promising antiviral protease inhibitors With no vaccine or proven effective drug against the virus that causes coronavirus disease 2019 (COVID-19), scientists are racing to find...

2020 Science 1546 citations

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Syed Faraz Ahmed , Ahmed Abdul Quadeer , Matthew R. McKay

The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is an immine...

2020 Viruses 1203 citations

Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

Cynthia Liu , Qiongqiong Angela Zhou , Yingzhu Li +8 more

Since the outbreak of the novel coronavirus disease COVID-19, caused by the SARS-CoV-2 virus, this disease has spread rapidly around the globe. Considering the potential threat ...

2020 ACS Central Science 1323 citations

Publication Info

Year: 2020
Type: article
Volume: 10
Issue: 4
Pages: 313-319
Citations: 1067
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1067

OpenAlex

Cite This

APA Style

                            
                                
                                    Muhammad Tahir ul Qamar, 
                                
                                    Safar M. Alqahtani, 
                                
                                    Mubarak A. Alamri
                                
                                et al.
                            
                            (2020). 
                            Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. 
                            Journal of Pharmaceutical Analysis
                            , 10
                            (4)
                            , 313-319.
                            https://doi.org/10.1016/j.jpha.2020.03.009
                        

Identifiers

DOI: 10.1016/j.jpha.2020.03.009